HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 12,200
+320 (2.69%)
Jun 24, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 171.32 billion as of June 24, 2026. Its market cap has decreased by -37.85% in one year.
Market Cap
171.32B
Enterprise Value
171.77B
Revenue
236.59B
Ranking
n/a
PE Ratio
107.80
Stock Price
12,200.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 171.32B, an increase of 103.27%. That is a compound annual growth rate of 6.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 171.32B | -23.94% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 197.90B |
| Suheung | 191.54B |
| Chong Kun Dang Holdings | 184.00B |
| Whan In Pharm | 181.33B |
| REYON Pharmaceutical | 181.21B |
| JW Lifescience | 173.89B |
| BNC KOREA | 170.65B |
| Daewon Pharmaceutical | 169.75B |